BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23315170)

  • 1. Prostaglandin E(2) regulates murine hematopoietic stem/progenitor cells directly via EP4 receptor and indirectly through mesenchymal progenitor cells.
    Ikushima YM; Arai F; Hosokawa K; Toyama H; Takubo K; Furuyashiki T; Narumiya S; Suda T
    Blood; 2013 Mar; 121(11):1995-2007. PubMed ID: 23315170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 represses interleukin 1 beta-induced inflammatory mediator output from pregnant human myometrial cells through the EP2 and EP4 receptors.
    Mosher AA; Rainey KJ; Giembycz MA; Wood S; Slater DM
    Biol Reprod; 2012 Jul; 87(1):7, 1-10. PubMed ID: 22517618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro.
    Choudhary S; Blackwell K; Voznesensky O; Deb Roy A; Pilbeam C
    Bone; 2013 Sep; 56(1):31-41. PubMed ID: 23639875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 stimulates cystogenesis through EP4 receptor in IMCD-3 cells.
    Elberg D; Turman MA; Pullen N; Elberg G
    Prostaglandins Other Lipid Mediat; 2012 May; 98(1-2):11-6. PubMed ID: 22503965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
    Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
    J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes.
    Harizi H; Grosset C; Gualde N
    J Leukoc Biol; 2003 Jun; 73(6):756-63. PubMed ID: 12773508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intact prostaglandin signaling through EP2 and EP4 receptors in stromal progenitor cells is required for normal development of the renal cortex in mice.
    Fuchs MAA; Schrankl J; Leupold C; Wagner C; Kurtz A; Broeker KA
    Am J Physiol Renal Physiol; 2022 Mar; 322(3):F295-F307. PubMed ID: 35037469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 promotes human CD34+ cells homing through EP2 and EP4 in vitro.
    Wang Y; Lai S; Tang J; Feng C; Liu F; Su C; Zou W; Chen H; Xu D
    Mol Med Rep; 2017 Jul; 16(1):639-646. PubMed ID: 28560401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of deletion of cyclooxygenase-2, prostaglandin receptor EP2, or EP4 in bone marrow cells on osteoclasts induced by mouse mammary cancer cell lines.
    Ono K; Akatsu T; Kugai N; Pilbeam CC; Raisz LG
    Bone; 2003 Nov; 33(5):798-804. PubMed ID: 14623055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 receptor subtype EP2- and EP4-regulated gene expression profiling in human ciliary smooth muscle cells.
    Reitmair A; Lambrecht NW; Yakubov I; Nieves A; Old D; Donde Y; Dinh D; Burk R; Sachs G; Im WB; Wheeler L
    Physiol Genomics; 2010 Aug; 42(3):348-60. PubMed ID: 20551148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse.
    Nataraj C; Thomas DW; Tilley SL; Nguyen MT; Mannon R; Koller BH; Coffman TM
    J Clin Invest; 2001 Oct; 108(8):1229-35. PubMed ID: 11602631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
    J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of eosinophils with endothelial cells is modulated by prostaglandin EP4 receptors.
    Konya V; Philipose S; Bálint Z; Olschewski A; Marsche G; Sturm EM; Schicho R; Peskar BA; Schuligoi R; Heinemann A
    Eur J Immunol; 2011 Aug; 41(8):2379-89. PubMed ID: 21681739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production.
    Nguyen M; Solle M; Audoly LP; Tilley SL; Stock JL; McNeish JD; Coffman TM; Dombrowicz D; Koller BH
    J Immunol; 2002 Oct; 169(8):4586-93. PubMed ID: 12370397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair.
    Zhang M; Ho HC; Sheu TJ; Breyer MD; Flick LM; Jonason JH; Awad HA; Schwarz EM; O'Keefe RJ
    J Bone Miner Res; 2011 Apr; 26(4):792-802. PubMed ID: 20939055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
    Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
    Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGE2 differentially regulates monocyte-derived dendritic cell cytokine responses depending on receptor usage (EP2/EP4).
    Poloso NJ; Urquhart P; Nicolaou A; Wang J; Woodward DF
    Mol Immunol; 2013 Jul; 54(3-4):284-95. PubMed ID: 23337716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous stimulation of EP2 and EP4 is essential to the effect of prostaglandin E2 in chondrocyte differentiation.
    Miyamoto M; Ito H; Mukai S; Kobayashi T; Yamamoto H; Kobayashi M; Maruyama T; Akiyama H; Nakamura T
    Osteoarthritis Cartilage; 2003 Sep; 11(9):644-52. PubMed ID: 12954235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4.
    Chun KS; Akunda JK; Langenbach R
    Cancer Res; 2007 Mar; 67(5):2015-21. PubMed ID: 17332329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle.
    Michael JV; Gavrila A; Nayak AP; Pera T; Liberato JR; Polischak SR; Shah SD; Deshpande DA; Penn RB
    FASEB J; 2019 Apr; 33(4):4780-4789. PubMed ID: 30601680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.